News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
CLARK IAN T
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| CLARK IAN T (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Exercised 6,703 restricted stock units
@ $0
Granted 8,803 options to buy
@ $38.005, valued at
$334.6k
Granted 6,776 restricted stock units
@ $0 |
|
| 06/08/2023 |
4
| CLARK IAN T (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 17,643 options to buy
@ $1.09, valued at
$19.2k
|
|
| 08/15/2022 |
4
| CLARK IAN T (Director) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $0.965, valued at
$14.5k
|
|
| 06/27/2022 |
4/A
| CLARK IAN T (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Granted 21,520 options to buy
@ $0 |
|
| 06/17/2022 |
4
| CLARK IAN T (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Granted 21,520 options to buy
@ $3.43, valued at
$73.8k
|
|
| 06/17/2022 |
4
| CLARK IAN T (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Exercised 2,198 restricted stock units
@ $0
Granted 8,789 options to buy
@ $38.42, valued at
$337.7k
Granted 6,703 restricted stock units
@ $0 |
|
| 06/17/2022 |
4
| CLARK IAN T (Director) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $0.9899, valued at
$14.8k
|
|
| 06/10/2022 |
4
| CLARK IAN T (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 17,478 options to buy
@ $1.06, valued at
$18.5k
|
|
| 05/24/2022 |
4
| CLARK IAN T (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Exercised 1,585 restricted stock units
@ $0 |
|
| 09/13/2021 |
4
| CLARK IAN T (Director) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $2.6, valued at
$39k
|
|
| 09/03/2021 |
4
| CLARK IAN T (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Sold 1,076 shares
@ $130, valued at
$139.9k
Exercised 1,076 options to buy
@ $4.18, valued at
$4.5k
|
|
| 07/01/2021 |
4
| CLARK IAN T (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Sold 10,559 shares
@ $130, valued at
$1.4M
Exercised 1,076 options to buy
@ $4.18, valued at
$4.5k
Exercised 4,840 options to buy
@ $77.09, valued at
$373.1k
|
|
| 06/21/2021 |
4
| CLARK IAN T (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Granted 3,135 options to buy
@ $117.19, valued at
$367.4k
Granted 2,198 restricted stock units
@ $0 |
|
| 06/16/2021 |
4
| CLARK IAN T (Director) has filed a Form 4 on Corvus Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $2.74, valued at
$41.1k
|
|
| 06/14/2021 |
4
| CLARK IAN T (Director) has filed a Form 4 on AVROBIO, Inc.|
Txns:
| Granted 17,438 options to buy
@ $9.63, valued at
$167.9k
|
|
| 06/10/2021 |
4
| CLARK IAN T (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Granted 21,520 options to buy
@ $27.66, valued at
$595.2k
|
|
| 06/02/2021 |
4
| CLARK IAN T (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Exercised 1,686 restricted stock units
@ $0 |
|
| 05/24/2021 |
4
| CLARK IAN T (Director) has filed a Form 4 on AGIOS PHARMACEUTICALS, INC.|
Txns:
| Granted 1,585 restricted stock units
@ $0
Granted 8,888 options to buy
@ $56.76, valued at
$504.5k
|
|
| 04/28/2021 |
4
| CLARK IAN T (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Sold 538 shares
@ $159.92, valued at
$86k
Exercised 538 options to buy
@ $4.18, valued at
$2.2k
|
|
| 03/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2021 |
4
| CLARK IAN T (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Sold 538 shares
@ $154, valued at
$82.9k
Exercised 538 options to buy
@ $4.18, valued at
$2.2k
|
|
| 01/27/2021 |
4
| CLARK IAN T (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Sold 538 shares
@ $162, valued at
$87.2k
Exercised 538 options to buy
@ $4.18, valued at
$2.2k
|
|
| 01/06/2021 |
4
| CLARK IAN T (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Sold 2,690 shares
@ $129.23, valued at
$347.6k
Exercised 2,690 options to buy
@ $4.18, valued at
$11.2k
|
|
| 12/30/2020 |
4
| CLARK IAN T (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Sold 538 shares
@ $135, valued at
$72.6k
Exercised 538 options to buy
@ $4.18, valued at
$2.2k
|
|
| 12/07/2020 |
4
| CLARK IAN T (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Sold 2,690 shares
@ $120, valued at
$322.8k
Exercised 2,690 options to buy
@ $4.18, valued at
$11.2k
|
|
| 11/27/2020 |
4
| CLARK IAN T (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Sold 538 shares
@ $113.28, valued at
$60.9k
Exercised 538 options to buy
@ $4.18, valued at
$2.2k
|
|
| 11/19/2020 |
4
| CLARK IAN T (Director) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Granted 209,690 options to buy
@ $4.406, valued at
$923.9k
Granted 21,520 options to buy
@ $19, valued at
$408.9k
|
|
| 11/18/2020 |
3
| CLARK IAN T (Director) has filed a Form 3 on Olema Pharmaceuticals, Inc. |
| 11/05/2020 |
4
| CLARK IAN T (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Sold 2,690 shares
@ $105.28, valued at
$283.2k
Exercised 2,690 options to buy
@ $4.18, valued at
$11.2k
|
|
| 10/28/2020 |
4
| CLARK IAN T (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Sold 538 shares
@ $104.03, valued at
$56k
Exercised 538 options to buy
@ $4.18, valued at
$2.2k
|
|
| 10/05/2020 |
4
| CLARK IAN T (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Sold 538 shares
@ $106.24, valued at
$57.2k
Sold 2,690 shares
@ $108.5, valued at
$291.9k
Exercised 538 options to buy
@ $4.18, valued at
$2.2k
Exercised 2,690 options to buy
@ $4.18, valued at
$11.2k
|
|
| 09/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2020 |
4
| CLARK IAN T (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Granted 3,341 shares
@ $0
Granted 4,840 options to buy
@ $77.09, valued at
$373.1k
|
|
|
|
|